Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2025 Mar 3;20(4):248–255. doi: 10.1159/000544967

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2025 S. Karger AG, Basel

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

PMC Copyright notice

Fig. 2. — IGM Treatment Consensus – results from first round voting (in this round, participants selected multiple options). Consensus was reached only for observation as the first-line treatment for Type 1 disease and patients in pregnancy/lactation. OBS, observation – regular monitoring without active intervention, except for drainage when necessary; ILS, intralesional steroid – steroid injection administered directly into the lesion; TOPS, topical steroid – steroid applied to the skin surface; SURG, surgical excision – surgical removal of the lesion; ABX, systemic antibiotics – antibiotics administered orally or intravenously; SS, systemic steroids – steroids taken orally or intravenously. IMT, immunosuppressive therapy – treatment that suppresses immune system activity (e.g., methotrexate, azathioprine); ATT, anti-tuberculosis therapy – medications specifically targeting tuberculosis infection; COMB, combination therapy – use of multiple treatment modalities together (e.g., SS + SURG/IMT/TOPS/ILS/ABX, IMT + SURG, etc.).